Live Breaking News & Updates on Clinical Decision Support Software Guidance

Stay updated with breaking news from Clinical decision support software guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Healthtech CEO Connect: Software As A Medical Device In The U.S. And EU Recap | MoFo Life Sciences


To embed, copy and paste the code into your website or blog:
On Friday, March 26, 2021, over 180 attendees worldwide attended McKinsey & Company’s first Global HealthTech CEO Connect of 2021. The discussion focused on regulatory and legal considerations for software as a medical device (SaMD) in both the United States and Europe and specific use cases for digital therapeutics and other digital health products. Speakers included Morrison & Foerster partners Bethany Hills and Wolfgang Schönig as well as special guest Corey McCann, president and CEO of Pear Therapeutics, in a fireside chat at the end of the program. 
Globally, the convergence of software technology and life sciences creates a massive opportunity for growth, and the market for these products is growing exponentially. Both the U.S. Food and Drug Administration (FDA) and European regulators have focused on establishing a regulatory framework for oversight of SaMD. ....

United States , Corey Mccann , Morrison Foerster , Eu Commission , International Medical Device Regulators Forum , Health Schemes Di , European Union , Mofo Life Sciences , Mckinsey Company , European Court , German Federal Institute For Drugs , Digital Health Apps , Eligibility Of Digital Health Applications For Reimbursement , Drug Administration , European Commission , Medicare Coverage Of Innovative Technology , Clinical Decision Support Software Guidance , Certification Pilot Program , Mofo Life , Global Healthtech , Bethany Hills , Wolfgang Sch , Pear Therapeutics , Pre Certification Pilot Program , Medicare Coverage , Innovative Technology ,